DrugPatentWatch Database Preview
Profile for United States of America Patent: 8754091
US Patent Family Members and Approved Drugs for United States of America Patent: 8754091
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Dec 28, 2026 | Pharmacyclics Inc | IMBRUVICA | ibrutinib |
➤ Try a Free Trial | Dec 28, 2026 | Pharmacyclics Inc | IMBRUVICA | ibrutinib |
➤ Try a Free Trial | Dec 28, 2026 | Pharmacyclics Inc | IMBRUVICA | ibrutinib |
➤ Try a Free Trial | Dec 28, 2026 | Pharmacyclics Inc | IMBRUVICA | ibrutinib |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |